In 2021, College of Pharmacy faculty were awarded more than $3.5 million in grants from such prestigious institutions as the National Institutes of Health, the American Society of Health System Pharmacists, and the VA Medical Center. This year’s awards brings the total list to 38 active grants at the College.
The following is a list of this year’s award recipients.
Dr. Michael Bartlett received a 1-year grant from MetCure Therapeutics for “Small-molecule therapy for bone metastatic castration-resistant prostate cancer” in the amount of $100,000.
Dr. Houjian Cai received a 2-year grant from the National Institutes of Health for “Blocking TMPRSS2 expression for prevention of SARS-CoV-2 infection” in the amount of $415,250.
Dr. David Crich received a 5-year grant from the National Institutes of Health for “Methods and Mechanisms in Carbohydrate Chemistry” in the amount of $1,556,007.
Dr. David Crich received a 2-year grant from the National Institutes of Health for “New Chemical Tools for the Synthesis of Trisubstituted Hydroxylamines and their Application as Bioisosteres in Medicinal Chemistry” in the amount of $408,640.
Dr. David Crich is the PI on a 1-year grant from Sunshine Biopharma for “In vivo efficacy and toxicology of SARS-PLpro Leads” in the amount of $259,805.
Dr. Ashley Hannings received a 6-month grant from UNC Chapel Hill for “Expansion of the Rural Research Alliance of Community Pharmacies” in the amount of $4,500.
Dr. Devin Lavender received a Rural Engagement Workshop Academic Faculty Seed Grant for “Creating Healthiest Georgia” in the amount of $5,000.
Dr. Priya Narayanan received a 4-year grant from VA Medical Center for “IPA for Fang Liu” in the amount of $293,890.
Dr. Andrea Sikora received a 2-year grant from ASHP for “Machine learning validation of medication regimen complexity for critical care pharmacist resource prediction” in the amount of $30,000.
Dr. Susan Smith received a ACCP Critical Care PRN Member Grant for “Pharmacokinetic analysis of IV push cefepime in critically ill patients with sepsis.”
Dr. George Zheng received a 2-year grant from the National Institutes of Health for “Develop Potent Methyltransferase Inhibitors to Target Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)” in the amount of $412,500.